Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BRBRVEthis companyBraveheart Bio, Inc.	$19.47	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BBIOBridgeBio Pharma, Inc.	$77.98	-20.18×	-7.27×	30.05×	-25.49×	-270.8%	94.4%	-113.3%	-145.3%	35.1%	-108.5%	-3.0%	-1.31×	-3.19×	-10.72×	2.62×	0.0%	2	-0.06	2	C
BCDABioCardia, Inc.	$0.90	-1.02×	9.31×	0×	-0.82×	-78.1%	0.0%	0.0%	0.0%	-919.3%	-581.7%	-89.3%	0.59×	0.25×	0×	1.12×	0.0%	1	-51.48	2	C
CYTKCytokinetics, Incorporated	$55.69	-9.72×	-11.56×	86.62×	-11.34×	-220.6%	88.5%	-695.4%	-891.6%	119.0%	-47.7%	-7.0%	-1.95×	-1.5×	-5.89×	4.53×	0.0%	2	-1.65	2	C
KARDKardigan, Inc.	$15.57	-6.88×	-5.27×	0×	-6.24×	-90.6%	0.0%	0.0%	0.0%	76.7%	-55.3%	-12.0%	-0.06×	0.49×	0×	9.2×	0.0%	—	—	2	C
RNAAtrium Therapeutics, Inc.	$8.32	-3.29×	1.22×	13.56×	0.18×	-210.6%	100.0%	-412.6%	-411.9%	-37.0%	-31.9%	-16.9%	0.02×	3.48×	0×	6.53×	0.0%	—	—	2	C+
Peer median	—	-6.88×	-5.27×	13.56×	-6.24×	-210.6%	88.5%	-113.3%	-145.3%	35.1%	-55.3%	-12.0%	-0.06×	0.25×	0×	4.53×	0.0%	2	-1.65	2	—